Eloah Rabello Suarez

762 total citations · 1 hit paper
21 papers, 593 citations indexed

About

Eloah Rabello Suarez is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Eloah Rabello Suarez has authored 21 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Eloah Rabello Suarez's work include CAR-T cell therapy research (8 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Eloah Rabello Suarez is often cited by papers focused on CAR-T cell therapy research (8 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Eloah Rabello Suarez collaborates with scholars based in Brazil, United States and Iran. Eloah Rabello Suarez's co-authors include Wayne A. Marasco, Jianhua Sui, Quan Zhu, Gordon J. Freeman, Sabina Signoretti, Jiusong Sun, Ghanbar Mahmoodi Chalbatani, Maria Aparecida da Silva Pinhal, Helena B. Nader and Seyed Amir Jalali and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Eloah Rabello Suarez

19 papers receiving 585 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution of cell therapy for renal cell carcinoma

2024 48 citations Yufei Wang, Eloah Rabello Suarez et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Eloah Rabello Suarez

Since Specialization

Citations

This map shows the geographic impact of Eloah Rabello Suarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eloah Rabello Suarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eloah Rabello Suarez more than expected).

Fields of papers citing papers by Eloah Rabello Suarez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eloah Rabello Suarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eloah Rabello Suarez. The network helps show where Eloah Rabello Suarez may publish in the future.

Co-authorship network of co-authors of Eloah Rabello Suarez

This figure shows the co-authorship network connecting the top 25 collaborators of Eloah Rabello Suarez. A scholar is included among the top collaborators of Eloah Rabello Suarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eloah Rabello Suarez. Eloah Rabello Suarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PD-L1 downregulation by carbonic anhydrase IX immunotherapy prompts immune checkpoint blockade in renal cell carcinoma 2025 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), Gabriela Sarti Kinker, (unknown), Wayne A. Marasco, Tiago da Silva Medina, Tiago G. Santos, Tiago Rodrigues, Eloah Rabello Suarez	0
2	CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient’s age, and tumor types 2024 ·BMC Cancer ·Erik Montagna, (unknown), (unknown), (unknown), Eloah Rabello Suarez	4
3	Evolution of cell therapy for renal cell carcinoma breakdown → 2024 ·Molecular Cancer ·Yufei Wang, Eloah Rabello Suarez, (unknown), (unknown), (unknown), (unknown), (unknown), Ghanbar Mahmoodi Chalbatani, (unknown), Wayne A. Marasco	48
4	Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer 2022 ·European Journal of Pharmaceutical Sciences ·Ming Zhong, Ghanbar Mahmoodi Chalbatani, (unknown), Qiuyi Li, (unknown), Michael R. Hamblin, Eloah Rabello Suarez, Lili Hu, Dingding Wang	5
5	Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy 2022 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Ghanbar Mahmoodi Chalbatani, (unknown), Bassam Janji, Eloah Rabello Suarez	30
6	Immune Checkpoint Blockade via PD-L1 Potentiates More CD28-Based than 4-1BB-Based Anti-Carbonic Anhydrase IX Chimeric Antigen Receptor T Cells 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Fernando Luiz Affonso Fonseca, Tiago da Silva Medina, Tiago G. Santos, Yufei Wang, Wayne A. Marasco, Eloah Rabello Suarez	11
7	Targeting Ca2+ and Mitochondrial Homeostasis by Antipsychotic Thioridazine in Leukemia Cells 2022 ·Life ·Vivian Moraes, (unknown), Eloah Rabello Suarez, Letícia Silva Ferraz, (unknown), Giuliana P. Mognol, (unknown), João Agostinho Machado‐Neto, Fábio Dupart Nascimento, Mirian A.F. Hayashi, Ivarne L.S. Tersariol, Donald D. Newmeyer, Tiago Rodrigues	6
8	Decreased levels of cathepsin Z mRNA expressed by immune blood cells: diagnostic and prognostic implications in prostate cancer 2021 ·Brazilian Journal of Medical and Biological Research ·(unknown), (unknown), (unknown), (unknown), Tiago Rodrigues, Marcelo Langer Wroclawski, Fernando Luiz Affonso Fonseca, Eloah Rabello Suarez	7
9	CAR-T cells: Early successes in blood cancer and challenges in solid tumors 2020 ·Acta Pharmaceutica Sinica B ·Hassan Dana, Ghanbar Mahmoodi Chalbatani, Seyed Amir Jalali, Hamid Reza Mirzaei, Stephan A. Grupp, Eloah Rabello Suarez, Catarina Rapôso, Thomas J. Webster	72
10	Abstract 3179: Design and activity of 2nd generation, dual-targeted CAR T cell factories against ccRCC 2019 ·Cancer Research ·Yufei Wang, Eloah Rabello Suarez, (unknown), Rebecca B. Jennings, Sabina Signoretti, Quan Zhu, Wayne A. Marasco	2
11	Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model 2016 ·Oncotarget ·Eloah Rabello Suarez, (unknown), Jiusong Sun, Jianhua Sui, Gordon J. Freeman, Sabina Signoretti, Quan Zhu, Wayne A. Marasco	281
12	Glycosaminoglycans affect heparanase location in CHO cell lines 2015 ·Glycobiology ·(unknown), Eloah Rabello Suarez, (unknown), Renan P. Cavalheiro, Helena B. Nader, Maria Aparecida da Silva Pinhal	9
13	The Profile of Heparanase Expression Distinguishes Differentiated Thyroid Carcinoma from Benign Neoplasms 2015 ·PLoS ONE ·Leandro Luongo Matos, Eloah Rabello Suarez, (unknown), Damila Cristina Trufelli, (unknown), (unknown), (unknown), (unknown), Jossi Ledo Kanda, Helena B. Nader, João Roberto Maciel Martins, Maria Aparecida da Silva Pinhal	17
14	Heparan sulfate mediates trastuzumab effect in breast cancer cells 2013 ·BMC Cancer ·Eloah Rabello Suarez, Edgar Julian Paredes‐Gamero, Auro del Giglio, Ivarne L.S. Tersariol, Helena B. Nader, Maria Aparecida da Silva Pinhal	21
15	Heparanase expression and glycosaminoglycans profile in renal cell carcinoma 2012 ·International Journal of Urology ·(unknown), Leandro Luongo Matos, (unknown), Eloah Rabello Suarez, (unknown), João Roberto Maciel Martins, Helena B. Nader, Antônio Carlos Lima Pompeo, Maria Aparecida da Silva Pinhal	13
16	Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases 2012 ·Clinical and Experimental Dermatology ·(unknown), Eloah Rabello Suarez, (unknown), (unknown), (unknown), João Paulo Tardivo, Francisco Macedo Paschoal, Maria Aparecida da Silva Pinhal	52
17	Selecting peptides for breast cancer treatment. 2012 ·Journal of Clinical Oncology ·Eloah Rabello Suarez, Helena B. Nader, Maria Aparecida da Silva Pinhal, Auro del Giglio	1
18	Trastuzumab resistance in breast cancer cell lines: The role of extracellular matrix. 2011 ·Journal of Clinical Oncology ·Maria Aparecida da Silva Pinhal, Eloah Rabello Suarez, Helena B. Nader, (unknown)	1
19	Glycosaminoglycan synthesis and shedding induced by growth factors are cell and compound specific 2007 ·Growth Factors ·Eloah Rabello Suarez, (unknown), (unknown), Leandro Luongo Matos, Helena B. Nader, Maria Aparecida da Silva Pinhal	6
20	A Phase I Study of Gemcitabine Combined with Vinblastine in Patients with Solid Tumors 2003 ·Tumori Journal ·(unknown), Eloah Rabello Suarez, Auro del Giglio	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact